Absolute Risk of Valvulopathy from Echo-Based Prevalence Surveys

Dexfen±Phen

Proportion with Valvulopathy

0

0

0

0

0

0

0

Khan

Overall

Wadden

Rasmussen

Glicklich

Khan

Bowen

0

0.1

0.2

0.3

0.4

0.5

0.6

Fen-Phen

Previous slide

Next slide

Back to first slide

View graphic version

9. Of note in this graphic display is the marked consistency across survey sites, as well as the nearly identical point estimates of absolute risk in both the fenfluramine and dexfenfluramine groups. The 95% confidence limits were somewhat broader for the dexfenfluramine group because the number of subjects was much smaller.